Physician profile
Matthew Cunningham-Hill
NPI 1275997348
$30,330.98
in general payments reported to CMS, 2019-2025
16 companies · $4,390 in 2025
The $4,390 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,000 · 2021: $5,684 · 2022: $6,324 · 2023: $7,903 · 2024: $1,031 · 2025: $4,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,460 · Food and Beverage: $4,520 · Travel and Lodging: $2,493 · Consulting Fee: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,460.00 |
| Food and Beverage | $4,520.35 |
| Travel and Lodging | $2,492.51 |
| Consulting Fee | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,579.63 | 2021-2025 | Endurant Iis, Harmony, Heli-Fx Endoanchor System |
| Novavax INC | $6,831.63 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Medtronic Vascular, INC. | $5,000.00 | 2020 | |
| Boston Scientific Corporation | $3,837.04 | 2022-2025 | Ekosonic, Ranger, Eluvia |
| W. L. Gore & Associates, INC. | $1,713.43 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Abbvie INC. | $850.00 | 2025 | |
| Endologix LLC | $460.14 | 2023-2024 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Shockwave Medical, INC | $407.48 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $182.53 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Lemaitre Vascular, INC. | $137.38 | 2022-2025 | Artegraft Vascular Graft |
| Terumo Medical Corporation | $134.40 | 2022-2025 | Glidesheath Slender |
| Ethicon US, LLC | $73.02 | 2024-2025 | Surgiflo Hemostatic Matrix, Vistaseal, Surgicel Nu-Knit |
| Bolton Medical INC | $45.72 | 2022 | |
| Stryker Corporation | $34.98 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Urgo Medical North America, LLC | $28.47 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $15.13 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cunningham-Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.